COVID-19 and the role of cytokines in this disease

A Hasanvand - Inflammopharmacology, 2022 - Springer
Studies have shown that SARS-CoV-2 has the ability to activate and mature proinflammatory
cytokines in the body. Cytokine markers are a group of polypeptide signalling molecules that …

Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation

B Bonnet, J Cosme, C Dupuis, E Coupez, M Adda… - …, 2021 - thelancet.com
Background SARS-CoV-2 has been responsible for considerable mortality worldwide, owing
in particular to pulmonary failures such as ARDS, but also to other visceral failures and …

Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers

Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

COVID-19 and Sepsis

ZK Tufan, B Kayaaslan, M Mer - Turkish journal of medical …, 2021 - journals.tubitak.gov.tr
The COVID-19 pandemic has created a major alteration in the medical literature including
the sepsis discussion. From the outset of the pandemic, various reports have indicated that …

Retrospective analysis of laboratory testing in 54 patients with severe-or critical-type 2019 novel coronavirus pneumonia

Y Li, Y Hu, J Yu, T Ma - Laboratory investigation, 2020 - nature.com
Timely analysis of the laboratory characteristics associated with 2019 novel coronavirus
pneumonia (COVID-19) can assist with clinical diagnosis and prognosis. This study is a …

Laboratory biomarkers associated with COVID-19 severity and management

S Keddie, O Ziff, MKL Chou, RL Taylor, A Heslegrave… - Clinical …, 2020 - Elsevier
The heterogeneous disease course of COVID-19 is unpredictable, ranging from mild self-
limiting symptoms to cytokine storms, acute respiratory distress syndrome (ARDS), multi …

Clinical utility of inflammatory biomarkers in COVID-19 in direct comparison to other respiratory infections—A prospective cohort study

M Lampart, N Zellweger, S Bassetti, S Tschudin-Sutter… - PloS one, 2022 - journals.plos.org
Background Inflammatory biomarkers are associated with severity of coronavirus disease
2019 (COVID-19). However, direct comparisons of their utility in COVID-19 versus other …

Immunologic features in coronavirus disease 2019: functional exhaustion of T cells and cytokine storm

S Mahmoudi, M Rezaei, N Mansouri, M Marjani… - Journal of clinical …, 2020 - Springer
To the Editor: Since the emergence of Coronavirus Disease 2019 (COVID-19) caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, the …

[HTML][HTML] Immune Response and COVID-19: A mirror image of Sepsis

E Lopez-Collazo, J Avendano-Ortiz… - … journal of biological …, 2020 - ncbi.nlm.nih.gov
The emergence of SARS-CoV-2 virus and its associated disease COVID-19 have triggered
significant threats to public health, in addition to political and social changes. An important …

[HTML][HTML] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta …

BM Henry, MHS De Oliveira, S Benoit… - Clinical Chemistry and …, 2020 - degruyter.com
Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …